All articles tagged with #migraine
Ronda Rousey explained that a migraine aura caused vision loss and slowed thinking during her 2015 defeat to Holly Holm, contributing to her UFC exit; after Cleveland Clinic treatment for the condition, she plans a final comeback bout against Gina Carano on Netflix’s first MMA card, aiming to retire on her own terms and influence the sport’s landscape.
Bryce Harper exited Saturday’s game against the Colorado Rockies in the first inning due to a migraine and was replaced by Felix Reyes; it marks the Phillies’ third migraine-related exit this season, though Harper had not missed a game previously, and entering 2026 he was batting .282 with nine homers and a .929 OPS.
Migraine is a neurological condition with four distinct phases—premonitory (24–48 hours before), aura (visual or sensory symptoms), headache, and postdrome (the “migraine hangover”). Understanding these stages helps people recognize early signs, treat symptoms effectively (early meds in the premonitory phase, migraine-specific meds like triptans during aura/headache, and preventive therapies for frequent attacks), and avoid overlapping attacks, while seeking medical advice for persistent or complex cases or hormone-related considerations in women with aura.
Researchers are widening the migraine toolbox with CGRP-targeting drugs that reduce attack frequency for many, Botox injections that can lower migraine frequency by blocking CGRP release, and neuromodulation devices that alter neural pain pathways—though responses vary, long-term relief isn’t universal and access to these therapies can be uneven.
Researchers are reframing migraine as a complex brain disorder rather than a simple trigger-based headache. Genetics (30–60% heritability) and brain processes like cortical spreading depression, plus immune activity in the meninges, are increasingly linked to attacks, while many‑so‑called triggers may actually be early symptoms. The peptide CGRP rises during attacks, enabling new CGRP‑targeting therapies that help many patients, yet migraine likely involves multiple intertwined pathways and varies across individuals.
The article discusses the often overlooked severity of primary headaches like migraines and cluster headaches, highlighting the limited research funding, the stigma surrounding these conditions, and recent advances in treatment such as CGRP blockers, while emphasizing the profound impact these headaches have on sufferers' lives.
Certain foods like fatty fish, fiber-rich fruits and vegetables, magnesium-rich greens, and hydrating fruits may help reduce migraine frequency and severity, while common triggers include alcohol, chocolate, and processed meats. A balanced, nutrient-rich diet focusing on anti-inflammatory and hydrating foods, along with avoiding known triggers, can support migraine management, though individual responses vary.
Certain foods like omega-3-rich fish, magnesium-rich greens, ginger, nuts, seeds, cinnamon, vitamin B2 foods, turmeric, whole grains, and water-rich fruits may help alleviate headaches and migraines, while avoiding triggers such as processed foods, caffeine, gluten, and alcohol can prevent them. Personalized approaches are important, and maintaining hydration, stress management, and a healthy diet are key to headache relief.
Eating specific foods such as omega-3-rich fish, magnesium-rich greens, ginger, nuts, seeds, cinnamon, vitamin B2 foods, turmeric, whole grains, and water-rich fruits can help alleviate headache and migraine symptoms when combined with healthy habits like hydration, exercise, sleep, and stress management. Conversely, triggers like chocolate, cheese, alcohol, gluten, caffeine, and processed foods should be avoided to prevent worsening symptoms.
A small Italian study suggests that GLP-1 drugs like liraglutide, used for weight loss, may also significantly reduce the frequency and severity of chronic migraines, independent of weight loss, indicating a potential new off-label use for these medications. Further research is needed to confirm these findings.
The article discusses ten home remedies that can help alleviate migraine symptoms, offering natural and accessible options for relief.
A pilot study suggests that GLP-1 agonists like liraglutide, originally used for diabetes and weight loss, may significantly reduce the frequency of chronic migraines, potentially through mechanisms independent of weight loss, such as lowering intracranial pressure. Further research is needed to confirm these findings.
A pilot study suggests that GLP-1 receptor agonists like liraglutide, similar to Ozempic, may significantly reduce the frequency of chronic migraines, with some patients experiencing up to a 75% reduction, potentially through lowering intracranial pressure, though further research is needed.
Early research suggests that the GLP-1 agonist liraglutide, used for diabetes and obesity, may significantly reduce migraine days, potentially through mechanisms involving brain pressure and CGRP reduction, but larger, controlled studies are needed to confirm these findings.
A small study suggests that GLP-1 drugs like liraglutide, used for diabetes and weight loss, may significantly reduce migraine days by lowering brain pressure, with promising results for future larger trials.